Adjuvanted-RSVPreF3 vaccine uptake and effectiveness in individuals with COPD: a nationwide Danish cohort study

20260 citationsJournal Articlediamond Open Access

Authors

María Solano Fonseca

Stanislava Bratković

Yunus Çolak · Gentofte Hospital

Marie Helleberg · Copenhagen University Hospital

Jørgen Vestbo · Gentofte Hospital

Sara Burns

Maria Spanggaard · Parthenope University of Naples

Kasper Løwe Lundgren · Parthenope University of Naples

Abstract

Adjuvanted-RSVPreF3 is highly effective in preventing RSV hospitalization in individuals aged ≥60 years with COPD. Disease outcomes could be improved by incorporating RSV vaccination into routine COPD management.

Topics & Keywords

Respiratory viral infections research Chronic Obstructive Pulmonary Disease (COPD) Research Viral gastroenteritis research and epidemiology

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Expert Review of Vaccines

Volume 25, Issue 1, pp. 2641671-2641671

DOI: 10.1080/14760584.2026.2641671

Field-Weighted Citation Impact: 0.00